Postbiotic Composition for Weight Loss via Propionibacterium freudenreichii
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Obesity is a growing health concern in the Western world, with increasing prevalence and associated negative health effects such as type 2 diabetes, heart disease, and certain cancers, for which existing compositions and methods for weight loss are not sufficiently effective.
Innovation Solution
The use of compositions comprising a postbiotic derived from Propionibacterium freudenreichii UF (UF1) for reducing body weight, body fat, and preventing obesity, which can be administered alone or in combination with other therapeutic agents or procedures such as gastric bypass surgery.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If existing compositions and methods are used for weight loss, then some weight reduction may be achieved, but the effectiveness is insufficient for addressing the growing obesity epidemic
Solution Approach 1:
The patent changes the biological parameter by introducing a specific probiotic strain (Propionibacterium freudenreichii UF1) with unique characteristics that enhance weight loss effectiveness. This strain produces specific metabolites and interacts with host metabolism in ways that existing compositions do not, thereby improving both reliability and productivity of weight loss outcomes
Solution Approach 2:
The invention creates a composite biological system by combining the probiotic P. freudenreichii UF1 with specific prebiotics and other therapeutic agents. This composite approach synergistically enhances weight loss effectiveness beyond what single agents can achieve, addressing the insufficiency of existing treatments
2Productivity
If aggressive weight loss methods are used, then faster weight reduction may be achieved, but health risks and side effects increase
Solution Approach 1:
The patent converts the potential harm of rapid weight loss into benefit by using a probiotic that naturally regulates metabolism. The P. freudenreichii UF1 strain produces metabolites that promote sustainable fat oxidation and improve insulin sensitivity, achieving effective weight loss while simultaneously reducing health risks associated with aggressive methods
Solution Approach 2:
The probiotic acts as a biological intermediary that mediates between dietary intake and energy expenditure. It produces signaling molecules and metabolites that gently regulate host metabolism, enabling effective weight loss without the harsh effects of extreme diets or medications
Data Source
AI summary
Disclosed herein are number embodiments relating to technologies for the use of postbiotic materials for the improvement of health. In certain embodiments, the composition is a postbiotic derived from at least one strain of bacteria wherein the at least one strain of bacteria comprises Propionibacterium freudenreichii UF (UF1). In certain specific embodiments contained in this disclosure, the postbiotic materials can lead to an reduction in body weight and an increase the portion of weight lost from fat rather than lean body mass.
